Dibutylone

Dibutylone
Names
	Systematic IUPAC name 1-(Benzo[d][1,3]dioxol-5-yl)-2-(dimethylamino)butan-1-one
	Other names 1-(1,3-Benzodioxol-5-yl)-2-(dimethylamino)butan-1-one; β-Keto-dimethylbenzodioxolylbutanamine; bk-DMBDB
Identifiers
CAS Number	802286-83-5 ; 17763-12-1 (HCl) ;
3D model (JSmol)	Interactive image;
ChemSpider	52084597;
PubChem CID	71308182;
UNII	Q13F1C1N8I ;
CompTox Dashboard (EPA)	DTXSID201016921 ;
	InChI InChI=1S/C13H17NO3/c1-4-10(14(2)3)13(15)9-5-6-11-12(7-9)17-8-16-11/h5-7,10H,4,8H2,1-3H3 Key: USEBIPUIVPERGC-UHFFFAOYSA-N;
	SMILES CCC(C(=O)c1ccc2c(c1)OCO2)N(C)C;
Properties
Chemical formula	C13H17NO3
Molar mass	235.283 g·mol−1
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references

Dibutylone (bk-DMBDB^[1]) is a stimulant drug of the amphetamine, phenethylamine, and cathinone drug classes. It is structurally related to butylone, a designer drug that has been detected in products marketed as bath salts or plant food.^[2]

In 2018, dibutylone was the third most common drug of the cathinone class to be identified in Drug Enforcement Administration seizures.^[3]

Legal status

In United States, dibutylone is on the list of Schedule I Controlled Substances as a positional isomer of pentylone.^[4]

^ "Southern Association of Forensic Scientists". Archived from the original on 2013-03-25. Retrieved 2012-12-12.
^ Krotulski, Alex J; Mohr, Amanda L A; Papsun, Donna M; Logan, Barry K (2018). "Dibutylone (bk-DMBDB): Intoxications, Quantitative Confirmations and Metabolism in Authentic Biological Specimens". Journal of Analytical Toxicology. 42 (7): 437–445. doi:10.1093/jat/bky022. PMID 29554274.
^ "Emerging Threat Report: Annual 2018" (PDF). Special Testing and Research Laboratory, Drug Enforcement Administration.
^ "Controlled Substances" (PDF). Drug Enforcement Administration.

This article about an organic compound is a stub. You can help Wikipedia by expanding it.